Cargando…

Open drug discovery in Alzheimer's disease

Alzheimer's disease (AD) drug discovery has focused on a set of highly studied therapeutic hypotheses, with limited success. The heterogeneous nature of AD processes suggests that a more diverse, systems‐integrated strategy may identify new therapeutic hypotheses. Although many target hypothese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Axtman, Alison D., Brennan, Paul E., Frappier‐Brinton, Tristan, Betarbet, Ranjita, Carter, Gregory W., Fu, Haian, Gileadi, Opher, Greenwood, Anna K., Leal, Karina, Longo, Frank M., Mangravite, Lara M., Edwards, Aled M., Levey, Allan I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192886/ https://www.ncbi.nlm.nih.gov/pubmed/37215505 http://dx.doi.org/10.1002/trc2.12394

Ejemplares similares

Discovery of FERM domain protein–protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer’s disease
por: Du, Yuhong, et al.
Publicado: (2023)

Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer’s disease
por: Du, Yuhong, et al.
Publicado: (2023)

Data Science Approaches for Effective Use of Mobile Device–Based Collection of Real‐World Data
por: Omberg, Larsson, et al.
Publicado: (2020)

The burning island: Spatiotemporal patterns of fire occurrence in Madagascar
por: Frappier-Brinton, Tristan, et al.
Publicado: (2022)

Structures of soluble guanylate cyclase: implications for regulatory mechanisms and drug development
por: Gileadi, Opher
Publicado: (2014)

Differential Phagocytic Properties of CD45(low) Microglia and CD45(high) Brain Mononuclear Phagocytes—Activation and Age-Related Effects
por: Rangaraju, Srikant, et al.
Publicado: (2018)

Pesticides and Parkinson’s Disease
por: Sherer, Todd B., et al.
Publicado: (2001)

Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins
por: Rangaraju, Srikant, et al.
Publicado: (2018)

Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM
por: Bashore, Frances M., et al.
Publicado: (2023)

RecQ helicases in DNA repair and cancer targets
por: Newman, Joseph A., et al.
Publicado: (2020)

Neuronal RING finger protein 11 (RNF11) regulates canonical NF-κB signaling
por: Pranski, Elaine L, et al.
Publicado: (2012)

A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation
por: Rangaraju, Srikant, et al.
Publicado: (2017)

Paramagnetic NMR in drug discovery
por: Softley, Charlotte A., et al.
Publicado: (2020)

Model organism development and evaluation for late‐onset Alzheimer's disease: MODEL‐AD
por: Oblak, Adrian L., et al.
Publicado: (2020)

Crystal structures of human soluble guanylate cyclase catalytic domains: promiscuity of the dimer interface and a potential allosteric site
por: Gileadi, Opher, et al.
Publicado: (2013)

Psychiatric blood biomarkers: avoiding jumping to premature negative or positive conclusions
por: Niculescu, A B, et al.
Publicado: (2015)

Crystal Structures of the Catalytic Domain of Human Soluble Guanylate Cyclase
por: Allerston, Charles K., et al.
Publicado: (2013)

Eurekometrics: Analyzing the Nature of Discovery
por: Arbesman, Samuel, et al.
Publicado: (2011)

Toward Autonomous Antibiotic Discovery
por: de la Fuente-Nunez, Cesar
Publicado: (2019)

Discovery of the Lyme Disease Agent
por: Barbour, Alan G., et al.
Publicado: (2019)

The AI for Scientific Discovery Network(+)
por: Kanza, Samantha, et al.
Publicado: (2021)

Pushing the boundaries of behavioral analysis could aid psychiatric drug discovery
por: Sweis, Brian M., et al.
Publicado: (2022)

Modulating biomolecular condensates: a novel approach to drug discovery
por: Mitrea, Diana M., et al.
Publicado: (2022)

Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer’s disease
por: Rayaprolu, Sruti, et al.
Publicado: (2020)

Recent advances in the structural molecular biology of Ets transcription factors: interactions, interfaces and inhibition
por: Cooper, Christopher D.O., et al.
Publicado: (2014)

Insights into the RecQ helicase mechanism revealed by the structure of the helicase domain of human RECQL5
por: Newman, Joseph A., et al.
Publicado: (2017)

Molecular Biology and Evolution of Cancer: From Discovery to Action
por: Somarelli, Jason A, et al.
Publicado: (2020)

Ten simple rules to power drug discovery with data science
por: Ferrero, Enrico, et al.
Publicado: (2020)

COVID-19: Growing Health Disparity Gaps and an Opportunity for Health Behavior Discovery?
por: Farmer, Nicole, et al.
Publicado: (2020)

The future of molecular dynamics simulations in drug discovery
por: Borhani, David W., et al.
Publicado: (2011)

VEGF and Intraocular Neovascularization: From Discovery to Therapy
por: Ferrara, Napoleone
Publicado: (2016)

New Entries in the Lottery of Facial GWAS Discovery
por: Claes, Peter, et al.
Publicado: (2016)

Archaeal imaging: leading the hunt for new discoveries
por: Bisson-Filho, Alexandre W., et al.
Publicado: (2018)

Penicillin’s Discovery and Antibiotic Resistance: Lessons for the Future?
por:  Lobanovska, Mariya, et al.
Publicado: (2017)

Biomarker discovery and beyond for diagnosis of bladder diseases
por: Jung, Sungyong, et al.
Publicado: (2020)

Antibacterial Discovery: 21st Century Challenges
por: Hoffman, Paul S.
Publicado: (2020)

NMR in target driven drug discovery: why not?
por: Keiffer, Sébastien, et al.
Publicado: (2020)

Platforms for Personalized Polytherapeutics Discovery in COVID-19
por: Hopkins, Christopher, et al.
Publicado: (2021)

Opportunities and Challenges of Data-Driven Virus Discovery
por: Lauber, Chris, et al.
Publicado: (2022)

Evolving paradigms for natural-product drug discovery
por: Cordell, Geoffrey A
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qv2regi3fbndi91h48rovek0l1